Le Lézard
Classified in: Health, Business
Subject: OTC

North American Cannabis Holdings January Sales Results Favorably Support Anticipated 50 Percent Increase In Current Quarter Sales Over Previous Quarter


DALLAS, January 26, 2017 /PRNewswire/ --

North American Cannabis Holdings, Inc. (USOTC: USMJ) today announced favorable sales performance since the beginning of 2017 reinforcing the Company's previously announced anticipated fifty percent (50%) increase in first calendar quarter sales of the previous quarter.  With approximately $500,000 in annual sales and averaging $125,000 in quarterly sales, the Company anticipates realizing an additional $60,000 in sales from January 1st through March 31st.

The Company recently entered into a new distribution agreement with a brand name drugstore to sell one of its pilot fitness, health and wellness supplements that is anticipated to add an additional $60,000 in sales in the first calendar quarter of 2017.  Results in the first few weeks of the year have been in line with the anticipated additional sales.

USMJ's Pilot Project Spinoff and Dividend Strategy 

Based on the personal experience of one of USMJ's founder with a daughter that discovered relief from a seizure disorder through the use of CBD, USMJ entered the cannabis sector piloting various cannabis enterprises in the fall of 2013.  The idea at first was to find one specific enterprise through the piloting process on which the Company could concentrate all its efforts.  What USMJ management discovered instead, is that the cannabis sector at large was in need of a business that could continuously connect investors and cannabis enterprise entrepreneurs.  The spinoff last year of a cannabis extraction enterprise into Puration, Inc. (USOTC: PURA) and the subsequent dividend of PURA stock to USMJ shareholders has been a milestone event in the construction of a sustainable operation that can continuously connect investors and cannabis entrepreneurs.  Now the Company has executed a second spinoff transaction with Alternet Systems, Inc. (USOTC: ALYI) and more are in the works.

To learn more about North American Cannabis Holdings: http://www.growusmj.com

Follow the Company on Twitter: twitter.com/US_HEMP

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

USMJ Contact: 
Steven Rash 
Phone: +1-972-528-0162

SOURCE North American Cannabis Holdings, Inc.


These press releases may also interest you

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...



News published on and distributed by: